Takeda Becomes the Latest to Notch an Alzheimer's Failure Under Its Belt Post author:Sam Post published:January 24, 2018 Post category:BioPharma Another experimental Alzheimer’s disease treatment has failed in a late-stage study. Source: BioSpace You Might Also Like OSE Immunotherapeutics Announces Strategic Multi-Year Research Collaboration With Memorial Sloan-Kettering Cancer Center In New York June 11, 2017 BioNTech Release: MammaTyper Enables More Precise Prediction Of The Response To Neoadjuvant Chemotherapy Compared To Manual Or Digitalized IHC February 14, 2017 This $4 Billion Asian Drugmaker With U.S. Ops Just Went on the Market September 25, 2017
OSE Immunotherapeutics Announces Strategic Multi-Year Research Collaboration With Memorial Sloan-Kettering Cancer Center In New York June 11, 2017
BioNTech Release: MammaTyper Enables More Precise Prediction Of The Response To Neoadjuvant Chemotherapy Compared To Manual Or Digitalized IHC February 14, 2017